A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT06488716 · TERMINATED
Trial details
- NCT number
- NCT06488716
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-16
- Primary completion
- 2025-11-05
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.